Testing effectiveness (Phase 2)Ended earlyNCT02504892
What this trial is testing
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Who this might be right for
Renal CancerBirt-Hogg-Dube Syndrome
National Cancer Institute (NCI) 3